Purchases and Sales Made in Q3 2023 in Acumen Pharmaceuticals, Inc. (ABOS)
This table provides information about the institutional ownership of Acumen Pharmaceuticals, Inc. (ABOS) during Q3 2023. The information is specifically focused on institutions that hold shares of Acumen Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 07, 2023
Q3 2023
|
Barclays PLC
London, X0 |
SELL
|
- |
-2.97K- 11.69% |
$12.3K - $28.9K
|
22.4K
$41.5K
|
|
|
Nov 14, 2023
Q3 2023
|
Ubs Oconnor LLC
Chicago, IL |
SELL
|
- |
-10K- 12.57% |
$41.5K - $97.2K
|
69.5K
$129K
|
|
|
Nov 14, 2023
Q3 2023
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-27.8K- 19.46% |
$115K - $270K
|
115K
$213K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
SELL
|
- |
-47.2K- 99.51% |
$196K - $458K
|
232
$429
|
|
|
Nov 14, 2023
Q3 2023
|
Knollwood Investment Advisory, LLC
Hunt Valley, MD |
SELL
|
- |
-50K- 2.98% |
$208K - $486K
|
1.63M
$3.01M
|
|
|
May 14, 2024
Q3 2023
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-57.4K- 50.06% |
$238K - $558K
|
57.3K
$106K
|
|
|
Nov 14, 2023
Q3 2023
|
Boothbay Fund Management, LLC
New York, NY |
SELL
|
- |
-65.9K- 51.86% |
$274K - $641K
|
61.2K
$113K
|
|
|
Nov 14, 2023
Q3 2023
|
Ikarian Capital, LLC
Dallas, TX |
SELL
|
- |
-340K- 51.86% |
$1.41M - $3.3M
|
315K
$583K
|
|
|
Nov 14, 2023
Q3 2023
|
Deep Track Capital, LP
Greenwich, CT |
SELL
|
- |
-1.4M- 35.83% |
$5.82M - $13.6M
|
2.51M
$4.65M
|